These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 29860219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
    Kay HY, Kim WD, Hwang SJ, Choi HS, Gilroy RK, Wan YJ, Kim SG.
    Antioxid Redox Signal; 2011 Oct 15; 15(8):2135-46. PubMed ID: 21504366
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease.
    Li X, Wang Z, Klaunig JE.
    Toxicology; 2018 Dec 01; 410():199-213. PubMed ID: 30120929
    [Abstract] [Full Text] [Related]

  • 7. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F, Wang Q, Lu M, Chen W, Song Y, Jing F, Guan Y, Wang L, Lin Y, Bo T, Zhang J, Wang T, Xin W, Yu C, Guan Q, Zhou X, Gao L, Xu C, Zhao J.
    J Hepatol; 2014 Dec 01; 61(6):1358-64. PubMed ID: 25016220
    [Abstract] [Full Text] [Related]

  • 8. miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder.
    Fan L, Lai R, Ma N, Dong Y, Li Y, Wu Q, Qiao J, Lu H, Gong L, Tao Z, Chen J, Xie Q, Ren J.
    J Hepatol; 2021 Jan 01; 74(1):8-19. PubMed ID: 32818571
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models.
    Zhang Y, Meng T, Zuo L, Bei Y, Zhang Q, Su Z, Huang Y, Pang J, Xiang Q, Yang H.
    Mar Drugs; 2017 Jun 03; 15(6):. PubMed ID: 28587208
    [Abstract] [Full Text] [Related]

  • 11. Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
    Haga S, Yimin, Ozaki M.
    BMC Gastroenterol; 2017 Jan 13; 17(1):9. PubMed ID: 28086800
    [Abstract] [Full Text] [Related]

  • 12. Hepatic lipid accumulation induced by a high-fat diet is regulated by Nrf2 through multiple pathways.
    Qiu S, Liang Z, Wu Q, Wang M, Yang M, Chen C, Zheng H, Zhu Z, Li L, Yang G.
    FASEB J; 2022 May 13; 36(5):e22280. PubMed ID: 35394671
    [Abstract] [Full Text] [Related]

  • 13. Ganoderma Lucidum Polysaccharide Peptide Alleviates Hepatoteatosis via Modulating Bile Acid Metabolism Dependent on FXR-SHP/FGF.
    Zhong D, Xie Z, Huang B, Zhu S, Wang G, Zhou H, Lin S, Lin Z, Yang B.
    Cell Physiol Biochem; 2018 May 13; 49(3):1163-1179. PubMed ID: 30196282
    [Abstract] [Full Text] [Related]

  • 14. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC, Liu BQ, Chen J, De J, Nima ZB, Dunzhu CR.
    J Ethnopharmacol; 2019 May 23; 236():316-325. PubMed ID: 30851372
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of LXRα-dependent steatosis and oxidative injury by liquiritigenin, a licorice flavonoid, as mediated with Nrf2 activation.
    Kim YW, Kim YM, Yang YM, Kay HY, Kim WD, Lee JW, Hwang SJ, Kim SG.
    Antioxid Redox Signal; 2011 Mar 01; 14(5):733-45. PubMed ID: 20677908
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.
    Nie H, Song C, Wang D, Cui S, Ren T, Cao Z, Liu Q, Chen Z, Chen X, Zhou Y.
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec 01; 1863(12):3087-3094. PubMed ID: 28951211
    [Abstract] [Full Text] [Related]

  • 17. Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation.
    Gai Z, Visentin M, Gui T, Zhao L, Thasler WE, Häusler S, Hartling I, Cremonesi A, Hiller C, Kullak-Ublick GA.
    Mol Pharmacol; 2018 Aug 01; 94(2):802-811. PubMed ID: 29743187
    [Abstract] [Full Text] [Related]

  • 18. [Effects of soothing liver and invigorating spleen recipes on SREBP-1c, SCD-1 mRNA and proteins expression in hepatocytes of NAFLD rats].
    Xu YJ, Yang QH, Han L, Zhang YP, Liu YZ, Jin L, Yan HZ.
    Zhong Yao Cai; 2014 Jan 01; 37(1):80-6. PubMed ID: 25090711
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway.
    Li M, Xu C, Shi J, Ding J, Wan X, Chen D, Gao J, Li C, Zhang J, Lin Y, Tu Z, Kong X, Li Y, Yu C.
    Gut; 2018 Dec 01; 67(12):2169-2180. PubMed ID: 28877979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.